Document Detail

Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products.
MedLine Citation:
PMID:  19808069     Owner:  NLM     Status:  MEDLINE    
Parenteral drug delivery systems can be designed to provide the flexible delivery characteristics needed in an evolving therapeutic landscape. The goal of some parenteral formulations is to maintain effective drug concentrations over a period of months or years, thereby enhancing patient compliance. When functioning as intended, these formulations can be used to minimize undesirable effects that may occur in response to the fluctuating drug concentrations effected by immediate release products. In other cases, targeted parenteral delivery systems allow for the deposition of drug directly to its site of action, thereby minimizing systemic toxicity. While these novel formulations can be beneficial to both human and veterinary patients, disastrous effects can occur if there is an unanticipated change in product quality or performance. With these thoughts in mind, the Controlled Release Society (CRS) hosted a 2007 workshop entitled "In Vitro and In Vivo Considerations Associated with Parenteral Sustained Release Products". The objective of that workshop was to explore the physicochemical properties of parenteral products and the factors that could alter their in vitro and in vivo performance characteristics. The outcomes of that workshop were summarized in a Journal of Controlled Release article. In response to questions raised during that workshop, the CRS and the American Association of Pharmaceutical Scientist (AAPS) co-hosted the follow-up 2008 workshop entitled "Critical Variables in the In Vitro and In Vivo Performance of Parenteral Sustained Release Products". This 2008 workshop provided a platform for exploring the application of design space concepts to these complex pharmaceuticals, and to consider the corresponding in vitro test methods that can be used to set batch release specifications. To foster discussion, the workshop provided two afternoon breakout sessions where critical questions were explored. This manuscript captures the results of those discussions.
Marilyn N Martinez; Michael J Rathbone; Diane Burgess; Mai Huynh
Related Documents :
10640589 - Drug release from biodegradable injectable thermosensitive hydrogel of peg-plga-peg tri...
17701529 - Synthesis, characterization, and evaluation of phosphated cross-linked konjac glucomann...
16076079 - Kinetic study of zinc sulphate release from lipophilic matrices prepared for the therap...
19831399 - In-vitro release kinetics and stability of anticardiovascular drugs-intercalated layere...
2052519 - Bead coating. i. change in release kinetics (and mechanism) due to coating levels.
16321489 - Ph-responsive amphiphilic hydrogel networks with ipn structure: a strategy for controll...
12776219 - The impact of drug-induced qt interval prolongation on drug discovery and development.
7154219 - Distribution of parelaphostrongylus tenuis (nematoda: metastrongyloidea) in white-taile...
12769359 - Sensing phenothiazine drugs at a gold electrode co-modified with dna and gold nanoparti...
Publication Detail:
Type:  Journal Article; Review     Date:  2009-10-03
Journal Detail:
Title:  Journal of controlled release : official journal of the Controlled Release Society     Volume:  142     ISSN:  1873-4995     ISO Abbreviation:  J Control Release     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-15     Completed Date:  2010-05-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607908     Medline TA:  J Control Release     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  2-7     Citation Subset:  IM    
Copyright Information:
Published by Elsevier B.V.
US Food and Drug Administration, Center for Veterinary, Medicine, Rockville, MD 20855, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Delivery Systems / methods*,  standards
Drug Design
Infusions, Parenteral / methods*,  standards
Quality Control

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Silk gland sericin protein membranes: Fabrication and characterization for potential biotechnologica...
Next Document:  A conceptual model of how US families with athletic adolescent daughters manage food and eating.